Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Int Regulatory News (ASAI)

Share Price Information for Asa Int (ASAI)

Share Price is delayed by 15 minutes
Get Live Data
274.00    10.00 (3.79%)
Bid:
270.00
Ask:
274.00
Spread: 4.00 (1.481%)
Market Cap: £267.99m
ASAI Live PriceLast checked at - London Stock Exchange

Intraday Asa Int Share Chart

Appointment of Karin Kersten as CEO

16 Jun 2023 07:00

RNS Number : 9177C
ASA International Group PLC
16 June 2023
 

Press Release

 

ASA International Group plc reports appointment of Karin Kersten as CEO

 

London, United Kingdom / Amsterdam, The Netherlands, 16 June 2023 - ASA International Group plc ('ASA International', the 'Company' or the 'Group'), one of the world's largest international microfinance institutions, today announces the appointment of Ms Karin Kersten as CEO of the Group as of 15 June 2023.

In line with the announcement by the Company on 24 February 2023, Mr. Dirk Brouwer, Co-Founder of ASA International stepped into a new role as of 15 June 2023.

After the AGM on 15 June 2013 the Board approved the appointment of Karin Kersten as CEO along with the appointment of Dirk Brouwer as (i) Deputy Chairman of the Board of ASA International and (ii) Special Adviser to the new CEO, the Executive Committee and the broader management team.

In his new role, the Company expects Dirk to (a) smoothen the path of transition and (b) support the new leadership going forward. In this capacity the Board fully expects Mr. Brouwer to continue to make a significant contribution to the strategic and operational development of the business for the foreseeable future.

At the AGM, the Shareholders also approved the appointment of Chris Low as Non-Executive Director (following his appointment to the Board on 1 February 2023). Chris has been appointed as Chair of Audit and Risk Committee as of 15 June 2023.

Gavin Laws retired as Non-Executive Director having joined the Board of ASA International on 22 January 2013.

Guy Dawson, Chairman of the Board, comments:

"As a Board, we congratulate Karin on her appointment as CEO of the Company. I am confident that we have the leadership in place to enable ASA International to continue to thrive in a turbulent world. Serving close to 2.5 million female clients, the Company is a strong advocate of female entrepreneurship. With Karin at the helm of our Company, we will further drive female leadership and diversity in our organisation."

"I would like to extend my gratitude to Dirk, being the co-founder of the Company, for his leadership and drive to build and grow the Company into one of the leading international microfinance institutions, as well as for his continued commitment to the Company in his new role."

"Gavin Laws will be retiring after ten years of service. We are sincerely grateful to Gavin for his steadfast and skilful contribution to the Board and wish him every success in his second retirement. We are fortunate to welcome in his stead Chris Low, who brings a wealth of relevant experience to the role of Non-Executive Director and Chairman of the Audit and Risk Committee."

This announcement contains information that qualified or may have qualified as inside information and is disclosed in accordance with the Market Abuse Regulation (EU) 596/2014 (as it applies in the UK pursuant to the European Union (Withdrawal) Act 2018) ('MAR').

Enquiries:

ASA International Group plc

Investor Relations

Mischa Assink ir@asa-intenational.com

 

About ASA International Group plc

ASA International Group plc (ASAI: LN) is one of the world's largest international microfinance institutions, with a strong commitment to financial inclusion and socioeconomic progress. The company provides small, socially responsible loans to low-income, financially underserved entrepreneurs, predominantly women, across South Asia, South East Asia, West and East Africa.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFFFAIEDSELM
Date   Source Headline
19th Jun 20263:56 pmRNSCorrection: Grant of Options
18th Jun 20267:00 amRNSGrant of Options
9th Jun 20268:34 amRNSFTSE All Share Index Inclusion
3rd Jun 20262:14 pmRNSResult of 2026 Annual General Meeting
21st May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20262:56 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSAppointment of Chairman and Board Update
30th Apr 20267:00 amRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSQ1 2026 Business Update
28th Apr 20267:00 amRNSAppointment of Independent Non-Executive Director
15th Apr 20267:00 amRNSFY 2025 Results
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
30th Jan 20261:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSQ4 2025 Trading and Business Update
13th Jan 20263:31 pmRNSHolding(s) in Company
9th Jan 20261:50 pmRNSDirector/PDMR Shareholding
9th Jan 20261:49 pmRNSDirector/PDMR Shareholding
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
17th Dec 20253:35 pmRNSAppointment of Non-Executive Director
4th Dec 20257:00 amRNSTrading Update
28th Nov 20259:36 amRNSHolding(s) in Company
10th Nov 20257:57 amRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSCFO Appointment
5th Nov 20255:31 pmRNSHolding(s) in Company
5th Nov 20255:27 pmRNSDirector/PDMR Shareholding
28th Oct 20252:20 pmRNSGrant of Options
27th Oct 20254:44 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSQ3 2025 Business Update
10th Oct 20253:29 pmRNSHolding(s) in Company
10th Oct 20253:28 pmRNSHolding(s) in Company
8th Oct 202512:44 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNS2025 Interim Results
11th Aug 202512:20 pmRNSDirector/PDMR Shareholding
30th Jul 20254:32 pmRNSHolding(s) in Company
29th Jul 202511:12 amRNSHolding(s) in Company
23rd Jul 20259:40 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSQ2 2025 Business Update
19th Jun 20252:13 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirectorate Change
20th May 20257:00 amRNSNotice of Annual General Meeting
24th Apr 20257:00 amRNS2024 Results
24th Apr 20257:00 amRNSAppointment of Independent Non-Executive Director
24th Apr 20257:00 amRNSQ1 2025 Business Update
20th Mar 20257:00 amRNSBoard and Leadership Update
10th Mar 202511:18 amRNSHolding(s) in Company
5th Mar 20254:27 pmRNSNotification of Major Holdings
5th Mar 20254:23 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.